RETATRUTIDE
Precision-formulated metabolic support peptide
Retatrutide is known as a triple receptor agonist because it targets three seperate metabolic hormone receptors simultaneously:
1. GLP-1 receptor
2. GIP receptor
3. Glucagon receptor
This combined mechanism is what makes retatrutide different from earlier peptide therapies.
1.
GLP-1
RECEPTOR
Appetite & Glucose Regulation
GLP-1 is a hormone released after eating. Activation may help:
Reduced appetite
Increase satiety
Slow gastric emptying
Support insulin secretion
Reduced food intake
WHY THE 3 RECEPTORS MATTER
Most peptides target 1 or 2 receptors.
Retarutide targets all 3 simultaneously, which may provide enhanced
metabolic support.
APPETITE CONTROL
Helps reduce hunger and increase feelings of fullness.
METABOLIC OPTIMISATION
Supports glucose regulation, insulin response and efficient nutrient use.
ENERGY & FAT UTILISATION
Supports increased energy expenditure and fat loss.
2.
Insulin Response & Metabolic Support
GIP supports nutrient metabolism.
Activation may help:
Enhance insulin release
Improve glucose control
Support nutrient utilisation
Promote fat metabolism
Support overall metabolism
GIP
RECEPTOR
3.
GLUCAGON RECEPTOR
Energy Expenditure & Fat Metabolism
The glucagon receptor in retatrutide.
Activation may help:
Increased energy expenditure
Enhanced fat oxidation
Promote lipolysis (fat breakdown)
Support metabolic activity
Aid in weight managment
TIRZEPATIDE
Precision-formulated metabolic support peptide
Trizepetide is a dual receptor agonist that targets GIP and GLP-1 receptors simultaneosly, helping to support blood sugar control, appetite regulation and metabolic health.
2.
Insulin Response & Metabolic Support
GIP supports nutrient metabolism.
Activation may help:
Enhance insulin release
Improve glucose control
Support nutrient utilisation
Promote fat metabolism
Support overall metabolism
GIP
RECEPTOR
WHY THE 2 RECEPTORS MATTER
Early peptide therapies target 1 receptor.
Trizepatide targets 2 receptors simultaneously, which may provide enhanced metabolic support.
metabolic support.
APPETITE CONTROL
Helps reduce hunger and increase feelings of fullness.
METABOLIC OPTIMISATION
Supports glucose regulation and efficent nutrient use.
ENERGY & FAT UTILISATION
Supports improved fat metabolism and energy utilisation as part of metabolic pathways.
1.
GLP-1
RECEPTOR
Appetite & Glucose Regulation
GLP-1 is a hormone released after eating. Activation may help:
Reduced appetite
Increase satiety
Slow gastric emptying
Support insulin secretion
Reduced food intake
CAGRILINITIDE
Precision-formulated metabolic support peptide
Cagrlinitide is an amylin analogue peptide designed to support appetite regulation and metabolic signalling pathways associated with satiety and gastric emptying.
1.
AMYLIN ANALOGUE
PATHWAY
Appetite & Glucose Regulation
Amylin is a naturally occuring hormone released alongside insulin after eating.
Activation may help
Support appetite regulation
Increase satiety
Slow gastric emptying
Support reduced food intake
Support metabolic signalling
CAGRILINITIDE
AMYLIN ANALOGU
Targeted Approach
Cagrilinitide mimics the action of amylin, a hormone involved in satiety and gastric emptying.
Distinct Mechanism
Works through amylin-associated signalling pathways, complementary to incretin-based therapies.
Purpose-Driven
Designed to support appetite control and metabolic signalling for long-term weight management goals.
WHY THE PATHWAY MATTERS
Traditional peptide therapies often focus on incretin pathways.
APPETITE REGULATION
Supports increased feelings of fullness and appetite.
GASTRIC EMPYING
Supports slower gastric emptying and prolonged satiety.
METABOLIC SUPPORT
Supports metabolic signalling associated with nutrient intake.